These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15737809)

  • 41. Sympathetic nerve blocks in mandibular herpes zoster and postherpetic neuralgia.
    Gomes RT; de Nazareth Pedras RB; da Silva JF; de Aguiar MC
    Headache; 2007 May; 47(5):728-30. PubMed ID: 17501858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Herpes zoster and postherpetic neuralgia: prevention and management.
    Mounsey AL; Matthew LG; Slawson DC
    Am Fam Physician; 2005 Sep; 72(6):1075-80. PubMed ID: 16190505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Family history as a risk factor for herpes zoster: a case-control study.
    Hicks LD; Cook-Norris RH; Mendoza N; Madkan V; Arora A; Tyring SK
    Arch Dermatol; 2008 May; 144(5):603-8. PubMed ID: 18490586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical experience of pain treatment for postherpetic neuralgia in elderly patients.
    Chau SW; Soo LY; Lu DV; Chen TI; Cheng KI; Chu KS
    Acta Anaesthesiol Taiwan; 2007 Jun; 45(2):95-101. PubMed ID: 17694685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peculiarities of herpes zoster in immunocompetent and immunocompromised hosts.
    Sharvadze L; Tsertsvadze T; Gochitashvili N; Bolokadze N; Dolmazashvili E
    Georgian Med News; 2006 Dec; (141):50-3. PubMed ID: 17261887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of vibrotactile thresholds with physical examination and electrophysiological assessment.
    Gerr F; Letz R; Hershman D; Farraye J; Simpson D
    Muscle Nerve; 1991 Nov; 14(11):1059-66. PubMed ID: 1745278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of the C64 quantitative tuning fork and the effect of niceritrol in diabetic neuropathy.
    Hotta N; Sugimura K; Tsuchida I; Sano T; Koh N; Matsumae H; Sakamoto N
    Clin Ther; 1994; 16(6):1007-15. PubMed ID: 7697680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Herpes zoster of the head and limbs: electroneuromyographic and clinical findings in 158 consecutive cases.
    Mondelli M; Romano C; Rossi S; Cioni R
    Arch Phys Med Rehabil; 2002 Sep; 83(9):1215-21. PubMed ID: 12235600
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of qualitative versus quantitative tuning forks: outcome measure for neuropathy.
    Lai S; Ahmed U; Bollineni A; Lewis R; Ramchandren S
    J Clin Neuromuscul Dis; 2014 Mar; 15(3):96-101. PubMed ID: 24534830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication.
    Gin H; Rigalleau V; Baillet L; Rabemanantsoa C
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):457-61. PubMed ID: 12522325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms.
    Pappagallo M; Oaklander AL; Quatrano-Piacentini AL; Clark MR; Raja SN
    Anesthesiology; 2000 Mar; 92(3):691-8. PubMed ID: 10719948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of herpes zoster and postherpetic neuralgia.
    Tyring SK
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S136-42. PubMed ID: 18021865
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of impaired glucose metabolism in the postherpetic neuralgia.
    Bosco D; Plastino M; De Bartolo M; Cristiano D; Ettore M; Zurlo G; Bosco F; Colica C; Tallarigo F; Fava A
    Clin J Pain; 2013 Aug; 29(8):733-6. PubMed ID: 23835767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the sensation in patients with trigeminal post-herpetic neuralgia.
    Alvarez FK; de Siqueira SR; Okada M; Teixeira MJ; de Siqueira JT
    J Oral Pathol Med; 2007 Jul; 36(6):347-50. PubMed ID: 17559496
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Herpes zoster vaccination: benefits and barriers.
    Komara FA
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S22-4. PubMed ID: 19553633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
    Betts RF
    J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effectiveness of prostaglandin E1 for the treatment of patients with neuropathic pain following herpes zoster.
    Kanai A; Osawa S; Suzuki A; Ishimaru R; Hoka S
    Pain Med; 2007; 8(1):36-40. PubMed ID: 17244102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nutrient deficiencies as a risk factor in Taiwanese patients with postherpetic neuralgia.
    Chen JY; Chu CC; Lin YS; So EC; Shieh JP; Hu ML
    Br J Nutr; 2011 Sep; 106(5):700-7. PubMed ID: 21473799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Postherpetic neuralgia: the never-ending challenge.
    Niv D; Maltsman-Tseikhin A
    Pain Pract; 2005 Dec; 5(4):327-40. PubMed ID: 17177766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.